Skip to main content
. 2021 Feb 1;118(6):e2017739118. doi: 10.1073/pnas.2017739118

Fig. 3.

Fig. 3.

WT mice repeated-dose bioavailability studies. (A) Accumulation of 32:6 n-3 in mouse retina and RPE after 15 d of gavage feeding (n = 6 mice/group). (B) Bioaccumulation of 32:6 n-3 in serum, RBC, and liver after 15 d of gavage feeding. No VLC-PUFAs were ever detectable in the brain. Data are presented as mean ± SEM (***P < 0.005; **P < 0.01; N.S.: not significant; N.D.: not detectable).